Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Catheter Administered Intracoronary Epinephrine in Prevention of No-Reflow in STEMI Patients Undergoing Primary Percutaneous Coronary Intervention

NCT06847568 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT06847568
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06847568 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Catheter Administered Intracoronary Epinephrine in Prevention of No-Reflow in STEMI Patients Undergoing Primary Percutaneous Coronary Intervention
Lead sponsor
Ain Shams University
Phase
Phase 3
Overall status
Recruiting
Start date
April 1, 2024
Completion date
April 30, 2026
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

no reflow phenomenon, st segment elevation myocardial infarction (stemi)